Literature DB >> 20495775

[Primary brain tumors and brain metastases. Symptomatic epilepsy and driving ability - systematic review and expert opinion].

P S Reif1, A Strzelczyk, S Rüegg, A H Jacobs, A Haag, A Hermsen, U Sure, S Knake, H M Hamer, H Strik, G Krämer, R Engenhart-Cabilic, F Rosenow.   

Abstract

PURPOSE: Primary brain tumors and metastases are common causes of symptomatic epilepsy. Seizures, neurological and neuropsychological deficits can interfere with driving ability. The present paper aims to systematically review the incidence of epileptic seizures in brain tumor patients and to discuss driving ability in the context of the current German guidelines and expert opinions.
METHODS: To evaluate the incidence of epileptic seizures which occur at the beginning and in the course of the disease, we performed a systematic literature research in PubMed from 1960 to 2007. Additionally on the basis of this data we performed a survey collecting expert opinions regarding the driving ability of brain tumor patients from members of the German working groups "Arbeitsgemeinschaft für prächirurgische Epilepsiediagnostik und operative Epilepsietherapie" (Working Group for Presurgical Epilepsy Diagnostics and Operative Epileptic Therapy) and "Neuroonkologische Arbeitsgemeinschaft" (Neuro-oncological Working Group).
RESULTS: The incidence of epileptic seizures depends on the entity, dignity and localization of the tumor. The driving ability of brain tumor patients is not explicitly regulated in Germany. Of the interviewed experts 72% judged the guidelines to be precise enough and 44% did not want to deprive the patients of their driving ability without a first seizure, independent of the individual risk. DISCUSSION: The available studies are methodologically insufficient and show that a further evaluation is necessary to assess the driving ability. Possible restrictions of the driving ability in patients with a high risk of seizures in the course of the disease have to take into account the balance between individual rights and the interests of the general public.

Entities:  

Mesh:

Year:  2010        PMID: 20495775     DOI: 10.1007/s00115-010-3011-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  73 in total

1.  MENTAL AND SEIZURE MANIFESTATIONS IN RELATION TO BRAIN TUMORS. A STATISTICAL STUDY.

Authors:  A GUEVENER; B K BAGCHI; K A KOOI; H D CALHOUN
Journal:  Epilepsia       Date:  1964-06       Impact factor: 5.864

2.  Epileptic seizures in supratentorial gliomas.

Authors:  P N Tandon; A K Mahapatra; A Khosla
Journal:  Neurol India       Date:  2001-03       Impact factor: 2.117

3.  [Epileptic seizure as the 1st symptom of a brain tumors].

Authors:  K Schürmann; M Brock
Journal:  Nervenarzt       Date:  1968-07       Impact factor: 1.214

4.  Glioblastoma multiforme in children.

Authors:  G J Dohrmann; J R Farwell; J T Flannery
Journal:  J Neurosurg       Date:  1976-04       Impact factor: 5.115

Review 5.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

6.  Preoperative and postoperative seizures in patients with astrocytic tumours: analysis of incidence and influencing factors.

Authors:  S L Hwang; A S Lieu; T H Kuo; C L Lin; C Z Chang; T Y Huang; S L Howng
Journal:  J Clin Neurosci       Date:  2001-09       Impact factor: 1.961

7.  Intracranial meningiomas in childhood.

Authors:  R C Chan; G B Thompson
Journal:  Surg Neurol       Date:  1984-04

8.  Prevalence and prognostic significance of epilepsy in patients with gliomas.

Authors:  K Lote; A E Stenwig; K Skullerud; H Hirschberg
Journal:  Eur J Cancer       Date:  1998-01       Impact factor: 9.162

9.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

10.  Epilepsy associated with pediatric brain tumors: the neuro-oncologic perspective.

Authors:  Avinoam Shuper; Isaac Yaniv; Shalom Michowitz; Liora Kornreich; Michael Schwartz; Hadassah Goldberg-Stern; Ian J Cohen
Journal:  Pediatr Neurol       Date:  2003-09       Impact factor: 3.372

View more
  1 in total

1.  Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes.

Authors:  Susan C Campbell; Carmen Muñoz-Ballester; Lata Chaunsali; William A Mills; Jennifer H Yang; Harald Sontheimer; Stefanie Robel
Journal:  Neurochem Int       Date:  2019-12-09       Impact factor: 3.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.